180 related articles for article (PubMed ID: 22039867)
21. Beyond platinums: gold complexes as anticancer agents.
Nardon C; Boscutti G; Fregona D
Anticancer Res; 2014 Jan; 34(1):487-92. PubMed ID: 24403506
[TBL] [Abstract][Full Text] [Related]
22. Non-classical structures among current platinum complexes with potential as antitumor drugs.
G Quiroga A
Curr Top Med Chem; 2011; 11(21):2613-22. PubMed ID: 22039872
[TBL] [Abstract][Full Text] [Related]
23. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
24. Polymer nanoparticle delivery of dichloroacetate and DACH-Pt to enhance antitumor efficacy and lower systemic toxicity.
Yang Q; Cai J; Sun S; Kang X; Guo J; Zhu Y; Yan L; Jing X; Wang Z
Biomater Sci; 2016 Apr; 4(4):661-9. PubMed ID: 26810463
[TBL] [Abstract][Full Text] [Related]
25. Platinum-based drugs: past, present and future.
Dilruba S; Kalayda GV
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1103-24. PubMed ID: 26886018
[TBL] [Abstract][Full Text] [Related]
26. Anticancer activity and tissue distribution of platinum (II) complex with lignin-derived polymer of benzene-poly-carboxylic acids.
Solovyev ND; Fedoros EI; Drobyshev EJ; Ivanenko NB; Pigarev SE; Tyndyk ML; Anisimov VN; Vilpan YA; Panchenko AV
J Trace Elem Med Biol; 2017 Sep; 43():72-79. PubMed ID: 27986470
[TBL] [Abstract][Full Text] [Related]
27. A Lipophilic Pt(IV) Oxaliplatin Derivative Enhances Antitumor Activity.
Abu Ammar A; Raveendran R; Gibson D; Nassar T; Benita S
J Med Chem; 2016 Oct; 59(19):9035-9046. PubMed ID: 27603506
[TBL] [Abstract][Full Text] [Related]
28. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
Bayram B; Ozgur A; Tutar L; Tutar Y
Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
[TBL] [Abstract][Full Text] [Related]
29. Glyconanoparticles for Targeted Tumor Therapy of Platinum Anticancer Drug.
Dag A; Omurtag Ozgen PS; Atasoy S
Biomacromolecules; 2019 Aug; 20(8):2962-2972. PubMed ID: 31314508
[TBL] [Abstract][Full Text] [Related]
30. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
Komeda S
Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
[TBL] [Abstract][Full Text] [Related]
31. A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors.
Rademaker-Lakhai JM; Terret C; Howell SB; Baud CM; De Boer RF; Pluim D; Beijnen JH; Schellens JH; Droz JP
Clin Cancer Res; 2004 May; 10(10):3386-95. PubMed ID: 15161693
[TBL] [Abstract][Full Text] [Related]
32. Targeting and delivery of platinum-based anticancer drugs.
Wang X; Guo Z
Chem Soc Rev; 2013 Jan; 42(1):202-24. PubMed ID: 23042411
[TBL] [Abstract][Full Text] [Related]
33. Polymeric drug delivery of platinum-based anticancer agents.
Haxton KJ; Burt HM
J Pharm Sci; 2009 Jul; 98(7):2299-316. PubMed ID: 19009590
[TBL] [Abstract][Full Text] [Related]
34. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
[TBL] [Abstract][Full Text] [Related]
35. The Platin-X series: activation, targeting, and delivery.
Basu U; Banik B; Wen R; Pathak RK; Dhar S
Dalton Trans; 2016 Aug; 45(33):12992-3004. PubMed ID: 27493131
[TBL] [Abstract][Full Text] [Related]
36. Satraplatin: an orally available platinum analog for the treatment of cancer.
Choy H
Expert Rev Anticancer Ther; 2006 Jul; 6(7):973-82. PubMed ID: 16831070
[TBL] [Abstract][Full Text] [Related]
37. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.
Rice JR; Gerberich JL; Nowotnik DP; Howell SB
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2248-54. PubMed ID: 16609041
[TBL] [Abstract][Full Text] [Related]
38. Multifunctional platinum-based nanoparticles for biomedical applications.
Cheng Q; Liu Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27094725
[TBL] [Abstract][Full Text] [Related]
39. A Drug of Such Damned Nature.1 Challenges and Opportunities in Translational Platinum Drug Research.
Cheff DM; Hall MD
J Med Chem; 2017 Jun; 60(11):4517-4532. PubMed ID: 28195724
[TBL] [Abstract][Full Text] [Related]
40. Novel platinum compounds and nanoparticles as anticancer agents.
Sarkar A
Pharm Pat Anal; 2018 Jan; 7(1):33-46. PubMed ID: 29227198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
